Ropes & Gray has represented Sanofi in a research collaboration with InduPro, Inc., pursuant to which Sanofi will have the right of first negotiation for InduPro’s bispecific PD-1 agonist program, which is currently in preclinical development for the treatment of autoimmune and inflammatory disorders. The partnership also featured a strategic equity investment by Sanofi in InduPro. The transactions were announced on Dec. 10.
The team included intellectual property transactions associate Parker Elliot, strategic transactions associate Derek Mubiru, venture capital and emerging companies partner Rajarshi Banerjee, health care partner David Peloquin, and litigation & enforcement partner Brendan Hanifin.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.